MedPath

University of Pennsylvania

University of Pennsylvania logo
🇺🇸United States
Ownership
Private
Established
1740-11-14
Employees
5K
Market Cap
-
Website
http://www.upenn.edu

Process Versus Outcomes Incentives for Lipid Management

Not Applicable
Completed
Conditions
Diabetes
Cardiovascular Disease
Interventions
Behavioral: Outcome Incentive
Behavioral: Process Incentive
First Posted Date
2014-09-23
Last Posted Date
2019-02-26
Lead Sponsor
University of Pennsylvania
Target Recruit Count
764
Registration Number
NCT02246959
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI

Phase 2
Completed
Conditions
Cognition Disorder
Traumatic Brain Injury
Attention Deficit Disorder
Interventions
First Posted Date
2014-08-26
Last Posted Date
2019-11-15
Lead Sponsor
University of Pennsylvania
Target Recruit Count
11
Registration Number
NCT02225106
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

Completed
Conditions
Memory Disorders
Perceptual Disorders
Intellectual Disability
First Posted Date
2014-08-25
Last Posted Date
2019-06-18
Lead Sponsor
University of Pennsylvania
Target Recruit Count
360
Registration Number
NCT02225041
Locations
🇺🇸

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

🇺🇸

Children's Memorial Hospital, Chicago, Chicago, Illinois, United States

🇺🇸

Johns Hopkins Children's Center, Baltimore, Maryland, United States

and more 28 locations

Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma

Phase 1
Terminated
Conditions
Patients With Residual or Reccurent EGFRvIII+ Glioma
Interventions
Biological: CART-EGFRvIII T cells
First Posted Date
2014-08-05
Last Posted Date
2023-06-22
Lead Sponsor
University of Pennsylvania
Target Recruit Count
11
Registration Number
NCT02209376
Locations
🇺🇸

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

🇺🇸

UCSF, San Francisco, California, United States

Choice Sets for Advance Directives

Not Applicable
Completed
Conditions
End Stage Renal Disease
Interventions
Behavioral: Expanded AD Choice
Behavioral: Expanded Life-sustaining Therapy Choice
First Posted Date
2014-08-05
Last Posted Date
2016-01-07
Lead Sponsor
University of Pennsylvania
Target Recruit Count
321
Registration Number
NCT02209038
Locations
🇺🇸

Willow Grove DaVita, Willow Grove, Pennsylvania, United States

🇺🇸

PDI Walnut Tower DaVita, Philadelphia, Pennsylvania, United States

🇺🇸

Abington DaVita, Willow Grove, Pennsylvania, United States

and more 12 locations

Using Biomarkers to Optimize Antibiotic Strategies in Sepsis

Not Applicable
Completed
Conditions
Sepsis
Interventions
Other: Biomarker Algorithm Intervention
First Posted Date
2014-08-01
Last Posted Date
2024-01-05
Lead Sponsor
University of Pennsylvania
Target Recruit Count
145
Registration Number
NCT02207114
Locations
🇺🇸

Hospital of the University of Pennsylvania - Medical Intensive Care Unit, Philadelphia, Pennsylvania, United States

Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes

Completed
Conditions
Familial Adenomatous Polyposis
Colorectal Cancer
Lynch Syndrome
Hnpcc
Map Syndrome
Interventions
Other: Epi proColon Testing
First Posted Date
2014-07-23
Last Posted Date
2019-08-28
Lead Sponsor
University of Pennsylvania
Target Recruit Count
24
Registration Number
NCT02198092
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

A Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia

Not Applicable
Completed
Conditions
Postoperative Complications
Hip Fracture
Delirium
Interventions
Other: Regional (spinal) Anesthesia
Other: General endotracheal anesthesia
First Posted Date
2014-07-15
Last Posted Date
2018-07-30
Lead Sponsor
University of Pennsylvania
Target Recruit Count
15
Registration Number
NCT02190903
Locations
🇺🇸

Hosptial of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)

Phase 4
Completed
Conditions
Psoriasis
Cardiovascular Disease
Interventions
Drug: Placebo
First Posted Date
2014-07-10
Last Posted Date
2019-08-15
Lead Sponsor
University of Pennsylvania
Target Recruit Count
43
Registration Number
NCT02187172
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

PATH For Triples Study: Medication and Lifestyle Adherence for HIV+ Patients

Not Applicable
Completed
Conditions
HIV
Interventions
Behavioral: PATH For Triples
Behavioral: Treatment as Usual
First Posted Date
2014-07-09
Last Posted Date
2019-10-04
Lead Sponsor
University of Pennsylvania
Target Recruit Count
129
Registration Number
NCT02185144
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath